Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A clinically applicable integrative molecular classification of meningiomas
Farshad Nassiri, Jeff Liu, Vikas Patil, et al.
Nature (2021) Vol. 597, Iss. 7874, pp. 119-125
Closed Access | Times Cited: 279

Showing 1-25 of 279 citing articles:

Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours
Craig Horbinski, Tamar Berger, Roger J. Packer, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 9, pp. 515-529
Closed Access | Times Cited: 172
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
Abrar Choudhury, Stephen T. Magill, Charlotte Eaton, et al.
Nature Genetics (2022) Vol. 54, Iss. 5, pp. 649-659
Open Access | Times Cited: 166
The WHO 2021 Classification of Central Nervous System tumours: a practical update on what neurosurgeons need to know—a minireview
Sverre H. Torp, Ole Solheim, Anne Jarstein Skjulsvik
Acta Neurochirurgica (2022) Vol. 164, Iss. 9, pp. 2453-2464
Open Access | Times Cited: 144
Brain borders at the central stage of neuroimmunology
Justin Rustenhoven, Jonathan Kipnis
Nature (2022) Vol. 612, Iss. 7940, pp. 417-429
Open Access | Times Cited: 100
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population
Yuanyuan Qu, Jinwen Feng, Xiaohui Wu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 81
DNA-framework-based multidimensional molecular classifiers for cancer diagnosis
Fangfei Yin, Haipei Zhao, Shasha Lu, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 6, pp. 677-686
Open Access | Times Cited: 68
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
William Chen, Abrar Choudhury, Mark W. Youngblood, et al.
Nature Medicine (2023) Vol. 29, Iss. 12, pp. 3067-3076
Open Access | Times Cited: 49
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Justin Z. Wang, Alexander Landry, David R. Raleigh, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 10, pp. 1742-1780
Open Access | Times Cited: 17
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Calixto‐Hope G. Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Nature Genetics (2024) Vol. 56, Iss. 6, pp. 1121-1133
Open Access | Times Cited: 12
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
Justin Z. Wang, Vikas Patil, Alexander Landry, et al.
Nature Medicine (2024) Vol. 30, Iss. 11, pp. 3173-3183
Open Access | Times Cited: 11
Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies
James C. Bayley, Caroline Hadley, Arif Harmanci, et al.
Science Advances (2022) Vol. 8, Iss. 5
Open Access | Times Cited: 58
Major Features of the 2021 WHO Classification of CNS Tumors
Heather Smith, Nitin R. Wadhwani, Craig Horbinski
Neurotherapeutics (2022) Vol. 19, Iss. 6, pp. 1691-1704
Open Access | Times Cited: 42
DNA methylation as a diagnostic tool
Kristyn Galbraith, Matija Snuderl
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 39
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features
Abrar Choudhury, William Chen, Calixto‐Hope G. Lucas, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 3, pp. 520-530
Open Access | Times Cited: 39
Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice
Frank Szulzewsky, Sonali Arora, Aleena Arakaki, et al.
Genes & Development (2022) Vol. 36, Iss. 13-14, pp. 857-870
Open Access | Times Cited: 35
Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
Guan-Hua Su, Yi Xiao, Chao You, et al.
Science Advances (2023) Vol. 9, Iss. 40
Open Access | Times Cited: 33
Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas
Grayson Herrgott, James M. Snyder, Ruicong She, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Justin Z. Wang, Vikas Patil, Jeff Liu, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 1, pp. 145-162
Open Access | Times Cited: 21
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors—A prospective study and guidelines for clinical testing
Kristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 21
Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma
A. Basit Khan, Collin W. English, William Chen, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 4, pp. 501-503
Open Access | Times Cited: 19
Time to Recurrence of Intracranial Meningiomas from a Monoinstitutional Surgical Series
Francesco Maiuri, Sergio Corvino, Giuseppe Corazzelli, et al.
World Neurosurgery (2024) Vol. 185, pp. e612-e619
Open Access | Times Cited: 10
Meningioma: current updates on genetics, classification, and mouse modeling
Frank Szulzewsky, H. Nayanga Thirimanne, Eric C. Holland
Upsala Journal of Medical Sciences (2024) Vol. 129, pp. e10579-e10579
Open Access | Times Cited: 7
Spinal Meningiomas: A Comprehensive Review and Update on Advancements in Molecular Characterization, Diagnostics, Surgical Approach and Technology, and Alternative Therapies
Danielle Dang, Luke Mugge, Omar Awan, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1426-1426
Open Access | Times Cited: 7
Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy
Abrar Choudhury, Martha A. Cady, Calixto‐Hope G. Lucas, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1823-1837
Closed Access | Times Cited: 7
cIMPACT-NOW Update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas
Felix Sahm, Kenneth Aldape, Priscilla K. Brastianos, et al.
Neuro-Oncology (2024)
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top